Owen La Rue, LLC Eli Lilly & CO Transaction History

Owen La Rue, LLC

$148 Million
Q2 2024

A detailed history of Owen La Rue, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Owen La Rue, LLC holds 5,417 shares of LLY stock, worth $4.8 Million. This represents 3.32% of its overall portfolio holdings.

Number of Shares

5,417

Previous 3,686 46.96%

Holding current value

$4.8 Million

Previous $2.87 Million 71.05%

% of portfolio

3.32%

Previous 1.92%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $1.25 Million - $1.57 Million	1,731 Added 46.96%	5,417 $4.9 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $104,227 - $139,441	-176 Reduced 4.56%	3,686 $2.87 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $1.12 Million - $1.32 Million	-2,125 Reduced 35.49%	3,862 $2.25 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $933,735 - $1.29 Million	2,148 Added 55.95%	5,987 $3.22 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $1.35 Million - $1.8 Million	3,839 New	3,839 $1.8 Million

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Owen La Rue, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Owen La Rue, LLC with notifications on news.

Account